Altimmune Inc (NASDAQ:ALT) has a beta value of 0.18 and has seen 2.25 million shares traded in the last trading session. The company, currently valued at $514.73M, closed the last trade at $7.26 per share which meant it gained $0.06 on the day or 0.83% during that session. The ALT stock price is -104.41% off its 52-week high price of $14.84 and 71.21% above the 52-week low of $2.09. The 3-month trading volume is 4.65 million shares.

Altimmune Inc (NASDAQ:ALT) trade information

Sporting 0.83% in the green in last session, the stock has traded in the green over the last five days, when the ALT stock price touched $7.26 or saw a rise of 11.79%. Year-to-date, Altimmune Inc shares have moved -35.47%, while the 5-day performance has seen it change 5.07%. Over the past 30 days, the shares of Altimmune Inc (NASDAQ:ALT) have changed -18.34%.

Altimmune Inc (ALT) estimates and forecasts

Figures show that Altimmune Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 206.33% over the past 6 months, with this year growth rate of -6.29%, compared to 10.50% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 5.00% and -18.80% for the next quarter. Revenue growth from the last financial year stood is estimated to be 9,681.70%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 35.74% over the past 5 years.

ALT Dividends

Altimmune Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.